VTN and age-related macular degeneration: Today, however, it is generally accepted that the complement-mediated molecular mechanisms driving AMD result from a mixture of both locally synthesised complement proteins (e.g., FD, FHL-1), as well as systemic complement proteins that are conferring an effect locally in tissues (e.g., FHRs).